Scientific educational event currently limited to Standard Licensed Cultivators in Canada. Tests abilities by starting competitors with identical genetics and determines winners via objective analyses at an unbiased laboratory.
KITCHENER, ON, April 26, 2019 /HalcyonTV/ - Qualis Cannabis Corporation ("Qualis"), is pleased to announce that they have signed a Letter of Intent with The Grow-Off LLC. ("TGO"). This deal allows Qualis to operate the Canadian Edition of the event, via its subsidiary The Grow Off Inc. (thegrowoff.ca).
Under this agreement, The Grow-Off Inc. will run all events in accordance with all applicable Canadian, and provincial laws.
"We are excited to announce our deal with The Grow-Off LLC. This is the first competition of its kind in Canada. We can't wait to showcase Canadian growing expertise to the world."
-Kevin Puloski, CEO, Qualis Cannabis
First of its kind in Canada
Both Qualis and TGO are firmly committed to scientific & educational bases for cannabis innovation. This alignment will showcase expert panels, public and private events, and access to cutting edge producer tech and services. The event kicks off in Spring/Summer 2019 ending with a private awards ceremony in Fall/Winter, honoring the best in potency, flavor, and yield.
The Grow-Off's Canadian Edition is continually searching for sponsorship partners from genetics providers to laboratory testing services, and participants for the 2019 launch.
"We are very excited to bring this competition to Canada. Qualis Cannabis has impressed us with their dedication to the Cannabis space."
-Samantha Sandt, Founder and CEO, The Grow-Off
About The Grow-Off LLC.
Founded in 2016 and headquartered in Colorado, U.S.A., The Grow-Off (https://thegrowoff.com/) has run the event 7 times in its quantitative quest for the best.
TGO's founders designed an innovative educational event that pits growers against each other using the same genetic base-line with judging based entirely on lab testing. Following resounding successes across multiple US states, the Canadian expansion is set to highlight cultivators in the industry's first federally legal G7 nation.
About Qualis Cannabis
Qualis (https://qualis.ca/) is a boutique biotech company showcasing its skill in domestic and foreign markets via a number of cutting-edge projects that now includes The Grow-Off Inc.
Subsidiaries include Northern Roots Cannabis and its Genetics Initiative. They are forging brilliant cannabis products and production-ready varieties through scientific innovation and a unique fair-trade cannabis cultivar platform. The continual, ethically-based intake of varieties from breeders and growers, paired with leading methodologies, increases yield, potency, pest-resistance, and intellectual property protection for any cultivar in any growing condition. This will enable cannabis extract and isolate production at lower cost, with higher yield. Qualis has developed partnership agreements with international pharmaceutical companies that see the intersection of its model with global industry trends.
Qualis is committed to ethical and environmental sustainability, industry stewardship, cultural respect, economic innovation, and social responsibility. Qualis is currently working with educational institutions, community groups, and legacy breeders to bring unique, protected, and potent strains to the international market for production in diverse environments. Northern Roots' Cannabis Genetics Initiative currently represents a library of pre-validated strains. (http://www.northernroots.co/)
Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
LOS ANGELES, April 24, 2019 /HalcyonTV/ -- Trendsetting, digitally-native makeup brand, Lime Crime, has announced the launch of its latest liquid lipstick – Lip Blaze. The brand recognizes that there is truly no one-nude-fits-all and is creating a uniquely universal range of nude lipstick hues to represent the entire nude-icorn rainbow.
The new Lip Blaze Cream Liquid Lipstick features the perfect hybrid of creamy goodness and shine infused with top-shelf cannabis sativa seed oil. Ideal for achieving the sought-after naked lip look and feel, this buttery high-drating formula delivers moisture that never feels sticky. Just a little dab of this cream liquid lipstick delivers primo moisture with an intoxicating OG lipstick scent with hints of rose and violet.
Lime Crime's Lip Blaze Cream Liquid Lipstick will be available in twelve nude lipstick shades: Cali (mauve nude), Jade (pale pink nude), Rosemary (light warm nude), Olive (chocolate brown), Apple (Caramel nude), Herb (terracotta nude), Cash (light nude), Moss (deep brown nude), Clover (rose nude), Fern (medium warm brown nude), Bud (medium terracotta brown nude), Ivy (mauve brown nude).
Lime Crime products are available on LimeCrime.com with all shades of Lip Blaze retailing for $20.
LAS VEGAS, April 23, 2019 /HalcyonTV/ - Planet 13 Holdings Inc. (CSE: PLTH) (OTCQB: PLNHF) ("Planet 13" or the "Company"), a leading vertically-integrated Nevada cannabis company, announced today that April 20, 2019 ("420") was the single biggest shopping day since the Company's Cannabis Entertainment Complex (the "SuperStore") opened on November 1, 2018.
Phase II construction remains on schedule for opening in Q3 2019. Phase II which includes a coffee shop, bistro, event space, and consumer-facing production facility is expected to drive additional awareness, traffic, and spend, cementing the Planet 13 SuperStore as a must-see destination for anyone from the cannabis curious to the cannabis connoisseur visiting Las Vegas.
About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQB under the symbol PLNHF.
FN Media Group Presents Potstocknews.com Market Commentary
NEW YORK, April 22, 2019 /HalcyonTV/ -- From candy and chocolate to infused beverages, the cannabis edibles market will hit $4.1 billion by 2022 according to a research report from ArcView. Now many in the industry are stocking up on new edible offerings, including Cannabis One Holdings Inc. (CSE:CBIS) (OTC:CAAOF), Canopy Growth Corp (NYSE:CGC) (TSX:WEED), Koios Beverage Corp. (CSE:KBEV)(OTC:KBEVF), Tilray, Inc. (NASDAQ:TLRY) and HEXO Corp. (NYSE:HEXO) (TSX:HEXO).
Unlike in Canada where delays and other challenges are being anticipated ahead of the proposed October 2019legalization, edibles are already legal and on shelves in multiple US states. Their popularity in places like Nevada, Washington, California, and Colorado has not been missed by companies like Cannabis One (CSE:CBIS) (OTC:CAAOF), which has strategically been amassing a portfolio that includes multiple popular edibles brands. This year, the company plans to integrate a number of brands into its portfolio including Evergreen Organix, West Edison Cannabis Concentrates, Fleur Cannabis, Strainz, Bronner and Honu.
Most recently, the company announced a definitive asset purchase agreement with the owners of the popular cannabis-infused product brands Evergreen Organix and EG.O. Over the years since its inception, Evergreen has made an impact in its home state of Nevada, winning numerous cannabis industry awards, including Best Edible and Best Edible Over All at the 2017 Jack Herer Cup, and reviewed as Best Edible by Reno News Review. The quality-driven edibles line is handcrafted by culinary artists, cutting no corners in the production of the product, and having widespread retail penetration. This partnership mimics the strategy of cannabis giant Canopy Growth Corp (NYSE:CGC) (TSX:WEED) - a large part of Canopy's success is due to intelligent acquisitions of edibles companies in anticipation of legalization.
Evergreen Organix is the second award-winning edibles addition to the Cannabis One (CBIS) (CAAOF) brand portfolio in the last month. Earlier in April, the company announced a definitive agreement to acquire select assets of Washington-based Honu Enterprises Inc.—one of few brands to win awards in multiple states and is estimated to yield US$20.3 million in annual system-wide brand revenue during fiscal 2019.
The potential for cannabis edibles is on the rise, as new states are looking to join the likes of California, Colorado, Nevada, and Washington in producing new cannabis-infused food products. Already, Michigan is bracing for a flood of marijuana-infused edibles, while medically-legal Florida is also moving closer to edibles sales. Leaders of the industry such as Tilray, Inc. (NASDAQ:TLRY) has been quietly acquiring edibles companies such as Natura in order to position themselves as a leader in these emerging markets.
Enhancing Pot's Value with Edibles
"With the addition of these popular Nevada marques to our growing portfolio of 'Best-of-Breed' brands, (CBIS) continues to demonstrate its ability to execute on its stated strategy – Acquire popular brands in vibrant markets and leverage that consumer enthusiasm into multi-state retail and manufacturing expansion," commented Jeffery Mascio, CEO of Cannabis One.
Upon the finalization of the acquisition, Cannabis One (CBIS-CAAOF) will gain a significant presence in the Nevada recreational medical marketplace. In terms of significance, Evergreen Organix has unprecedented retail penetration levels for its brands, appearing in approximately 95.0% of State-licensed dispensary locations.
Together with Evergreen's management, Cannabis One (CBIS-CAAOF) estimates the addition of US$20.8 million in annual system-wide brand revenue through the Evergreen channel, during fiscal 2019. Much of the expectation is enhanced by the value proposition brought to the table by Cannabis One's brand portfolio presence.
"Evergreen believes CBIS represents an exceptional value proposition and a valued industry partner through which to launch the next phase of our progressive state-legal expansion program," said Evergreen's President, Jerry Velarde, who will be joining the Cannabis One team as Chief Marketing Officer. "Having already established a reputation centered around brand quality and consistency in the minds of cannabis consumers – we are excited to jointly announce the contribution of our Evergreen suite of brands to Cannabis One's growing 'House of Brands'."
Along with Evergreen Organix, the agreement also included the popular flower brand, Fleur — which fits with Cannabis One's other flower brand offerings that now include Fat Face Farms and Cheech's Private Stash. Acquisitions like these set Cannabis One (CSE:CBIS)(OTC:CAAOF) up to jockey for partnerships with even larger corporations, such as HEXO Corp. (NYSE:HEXO) (TSX:HEXO) who recently announced a partnership with beverage manufacturing giant Molson Coors Canada back in January, to produce CBD-infused beverages through a newly formed joint venture company named Truss.
Further Market Edibles Activities
Ontario-based cannabis giant Canopy Growth Corp (CGC-WEED) has ramped up the pace of its packaging and shipping processes while anticipating sales growth in the final quarter of the calendar year as more stores open their doors and edibles hit the market. A year ahead of the anticipated Canadian legalization of edibles, Canopy partnered with widely recognized chocolatiers Hummingbird to produce a jointly made product. Given that the Canopy facility is located within a former Hershey plant in Smiths Falls, once again the site will produce chocolate. Canopy also is anticipating the launch of its joint beverage products with Corona makers, Constellation Brands.
Much like Canopy, Tilray, Inc. (TLRY) has also announced a partnership with a major beverage company—big beermaker Anheuser-Busch InBev. Together they're set to research cannabis-infused nonalcoholic beverages for potential introduction in the Canadian market once cannabis edibles are allowed.
Quebec-based HEXO Corp. (NYSE:HEXO) (TSX:HEXO) is also looking into producing its own edibles products, as well as anticipating potential partnerships with further Fortune 500-level companies in the food, cosmetics, and tobacco industries which could very likely have interest in entering the cannabis sector.
Koios Beverage Corp. (CSE:KBEV)(OTC:KBEVF) is also teaming up with well-known organizations, announcing an agreement to sponsor TedXMileHigh this June in Denver. Koios is an emerging functional beverage company with a subsidiary -- Cannavated Beverage Corp. -- focused on the CBD-infused beverage market. Koios has an available distribution network of 5,000+ retail locations after signing a strategic partnership with GNC and will leverage these for Cannavated as the markets become legal.
For a FREE research report on Cannabis One Holdings Inc. (CSE:CBIS) (OTC:CAAOF), visit www.potstocknews.com
Disclaimer: Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of Cannabis One Holdings Inc.
LONDON, April 8, 2019 /HalcyonTV/ -- This June, London will play host to the first official European Cannabis Week, a series of events delving into all aspects of Europe's emerging medical cannabis industries, the CBD boom and the politics and culture of this once controversial plant.
Taking place at various venues across the capital from 23rd to 29th June, speakers will discuss topics including politics, science, health, patient needs, advocacy, investment and culture while networking and enjoying the best the city has to offer.
European Cannabis Week will be the first major showcase of Europe's emerging legal CBD and medical cannabis industries and the first major set of cannabis events in the UK since the government legalised medical cannabis. The series of events will take place against a backdrop of major global policy change, as a number of European governments move to overhaul the continent-wide moratorium on cannabis and WHO re-examines their position on medical cannabis.
While medical cannabis may be the hot topic at the moment, CBD is still firmly on the agenda, as the European Parliament looks at changing its legislation.
Alastair Moore, COO of European Cannabis Week explained the need for such an event:
"Legislation in Europe is changing at a rapid pace and the private sector is evolving to serve the ever-growing demand for medical cannabis. Sixteen European countries have now legalised medical cannabis and with a total market of over 740 million people, Europe will become the largest value cannabis market in the world. European Cannabis Week will drive this growth, bringing together the people, brands and organisations that will shape the emerging European market."
Further information detailing speakers, brands and venues will be released soon. To stay up to date, sign up to our mailer on the ECW website.
To apply for press passes, email email@example.com - Please note that places are limited.
Cannabis Europa London will be the headline event of the week, but media accreditation will be separate.
To apply for a press pass, or for any media-related inquiries please email Press@ecwevents.com
About European Cannabis Week
A first for Europe, a first for London and a first for the cannabis industry. European Cannabis Week is a carefully curated series of events that showcase the depth of talent, opportunity and excitement of the European cannabis industry. The diverse programme of talks and events will explore the culture, politics, health, science and business behind the emergent cannabis industry in Europe, featuring a diverse roster of speakers from across the world. Hosted from June 23rd to 29th the festival takes place in venues across London, a European hub for finance, culture and creativity.